Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF PILL
17.32 USD +0.47 (+2.79%)
At closeNov 10, 2026, 4:00 PM EST
17.39 +0.07 +0.40%
After hours · Nov 10, 4:00 PM ET
16.44 Day range 17.33
8.62 52-week range 24.15
- YTD
- +40.81%
- 1 year
- +100.93%
- Market cap
- 34.93M
- EPS (ttm)
- 0.873814
- P/E ratio
- 19.82
- YTD return
- +40.81%
- 1-year return
- +100.93%
- Volume
- 88.56K
- Avg volume
- 54.96K
- Open
- 16.83
- Previous close
- 16.85
- Day's range
- 16.44 – 17.33
- 52-week range
- 8.62 – 24.15
5D +1.67 (+10.67%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 8.83
- 200-day average
- 7.64
About Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF
The fund invests at least 80% of its net assets in financial instruments, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective. The index is a modified equal-weighted index that is designed to measure performance of the stocks comprising the S&P Total Market Index that are classified in the GICS pharmaceuticals sub-industry. The fund is non-diversified.
News
Top Performing Leveraged/Inverse ETFs: 06/14/2026 
Trump Unveils 'Great Healthcare Plan,' Takes Aim At PBM 'Kickbacks' 
Top Performing Leveraged/Inverse ETFs: 12/14/2025 
Top Performing Leveraged/Inverse ETFs: 11/16/2025 
Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermediate Them Easily' 
Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms 
As M&A Deals Rise, Can Biotech Pharma Break Loose? 
Mark Cuban Exposes How Wholesalers Force Pharmacies Into Near-Exclusive Deals, Detailing PBMs' 'Stranglehold' On Drug Pricing 
Top Performing Leveraged/Inverse ETFs: 08/17/2025 
CURE: Make an Adventurous Bet on an Undervalued Sector
Your note
Sign in to keep a note on PILL — it syncs with the Stock Master app.